nodes	percent_of_prediction	percent_of_DWPC	metapath
Lucanthone—TOP2A—adrenal gland cancer	0.915	1	CbGaD
Lucanthone—TOP1—Circadian rythm related genes—SFPQ—adrenal gland cancer	0.00642	0.124	CbGpPWpGaD
Lucanthone—APEX1—adrenal cortex—adrenal gland cancer	0.00483	0.145	CbGeAlD
Lucanthone—APEX1—gonad—adrenal gland cancer	0.004	0.12	CbGeAlD
Lucanthone—APEX1—cardiac atrium—adrenal gland cancer	0.004	0.12	CbGeAlD
Lucanthone—APEX1—pituitary gland—adrenal gland cancer	0.00391	0.117	CbGeAlD
Lucanthone—APEX1—adrenal gland—adrenal gland cancer	0.00349	0.105	CbGeAlD
Lucanthone—TOP1—adrenal cortex—adrenal gland cancer	0.00338	0.102	CbGeAlD
Lucanthone—APEX1—TSH signaling pathway—TSHR—adrenal gland cancer	0.00296	0.0574	CbGpPWpGaD
Lucanthone—TOP1—cardiac atrium—adrenal gland cancer	0.0028	0.084	CbGeAlD
Lucanthone—APEX1—Extension of Telomeres—TERT—adrenal gland cancer	0.00279	0.0541	CbGpPWpGaD
Lucanthone—TOP1—pituitary gland—adrenal gland cancer	0.00273	0.082	CbGeAlD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.00266	0.0516	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.00247	0.0479	CbGpPWpGaD
Lucanthone—TOP1—adrenal gland—adrenal gland cancer	0.00244	0.0733	CbGeAlD
Lucanthone—TOP2A—Circadian rythm related genes—SFPQ—adrenal gland cancer	0.00201	0.0388	CbGpPWpGaD
Lucanthone—TOP2A—adrenal gland—adrenal gland cancer	0.00174	0.0522	CbGeAlD
Lucanthone—APEX1—TSH signaling pathway—GNAS—adrenal gland cancer	0.00172	0.0334	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—IGF1R—adrenal gland cancer	0.00168	0.0326	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.00153	0.0296	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.00147	0.0284	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—RRM1—adrenal gland cancer	0.00145	0.0281	CbGpPWpGaD
Lucanthone—APEX1—Telomere Maintenance—TERT—adrenal gland cancer	0.00127	0.0245	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—BRAF—adrenal gland cancer	0.00115	0.0222	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CDC42—adrenal gland cancer	0.00113	0.022	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—RB1—adrenal gland cancer	0.00113	0.0218	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.00107	0.0207	CbGpPWpGaD
Lucanthone—APEX1—Chromosome Maintenance—TERT—adrenal gland cancer	0.00106	0.0204	CbGpPWpGaD
Lucanthone—APEX1—Synthesis of DNA—RB1—adrenal gland cancer	0.000835	0.0162	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.000832	0.0161	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.000797	0.0154	CbGpPWpGaD
Lucanthone—APEX1—DNA Replication—RB1—adrenal gland cancer	0.000783	0.0152	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.000773	0.015	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—RB1—adrenal gland cancer	0.000708	0.0137	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—CTNNB1—adrenal gland cancer	0.000701	0.0136	CbGpPWpGaD
Lucanthone—APEX1—S Phase—RB1—adrenal gland cancer	0.000685	0.0133	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—adrenal gland cancer	0.000601	0.0116	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.000586	0.0113	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—PTGS2—adrenal gland cancer	0.000582	0.0113	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—EGFR—adrenal gland cancer	0.000556	0.0108	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.000524	0.0102	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—TOP2A—adrenal gland cancer	0.0005	0.00968	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—TP53—adrenal gland cancer	0.000467	0.00904	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TOP2A—adrenal gland cancer	0.000447	0.00866	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—PRKACA—adrenal gland cancer	0.00044	0.00853	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—RB1—adrenal gland cancer	0.000418	0.00809	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	0.000415	0.00805	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—EGFR—adrenal gland cancer	0.000412	0.00799	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—PRKACA—adrenal gland cancer	0.000394	0.00762	CbGpPWpGaD
Lucanthone—Amiodarone—ABCB1—adrenal gland cancer	0.000369	0.678	CrCbGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	0.000349	0.00675	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—TP53—adrenal gland cancer	0.000346	0.00671	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—TP53—adrenal gland cancer	0.000335	0.00648	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.000334	0.00648	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—RB1—adrenal gland cancer	0.000294	0.00569	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TERT—adrenal gland cancer	0.000268	0.00519	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDKN2A—adrenal gland cancer	0.000258	0.005	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.000249	0.00482	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—RB1—adrenal gland cancer	0.000233	0.00452	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—RB1—adrenal gland cancer	0.000208	0.00404	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	0.000205	0.00397	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—TP53—adrenal gland cancer	0.000204	0.00396	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—PRKACA—adrenal gland cancer	0.000204	0.00394	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDKN2A—adrenal gland cancer	0.000183	0.00355	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.000183	0.00355	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—PRKACA—adrenal gland cancer	0.000182	0.00353	CbGpPWpGaD
Lucanthone—Flurazepam—ABCB1—adrenal gland cancer	0.000175	0.321	CrCbGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.000164	0.00317	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	0.00013	0.00251	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TERT—adrenal gland cancer	0.000124	0.0024	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	0.000109	0.00211	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—RB1—adrenal gland cancer	0.000108	0.00209	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—TP53—adrenal gland cancer	0.000105	0.00203	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TP53—adrenal gland cancer	0.000102	0.00198	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—RB1—adrenal gland cancer	9.64e-05	0.00187	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	9.48e-05	0.00184	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDKN2A—adrenal gland cancer	8.47e-05	0.00164	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TP53—adrenal gland cancer	4.72e-05	0.000913	CbGpPWpGaD
